Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,363 | 6,608 | 8,702 | 7,401 | 38,802 |
| Marketable Securities | N/A | N/A | 3,050 | 13,762 | N/A |
| Other current assets | 117 | 169 | 547 | 282 | 114 |
| TOTAL | $8,480 | $6,777 | $12,299 | $21,445 | $38,916 |
| Non-Current Assets | |||||
| PPE Net | 10 | 24 | 42 | 66 | 28 |
| Investments And Advances | 0 | 0 | 0 | 2,352 | 0 |
| Other Non-Current Assets | 46 | 24 | 24 | 766 | 630 |
| TOTAL | $56 | $48 | $66 | $3,184 | $658 |
| Total Assets | $8,536 | $6,825 | $12,365 | $24,629 | $39,574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 418 | 230 | 622 | 1,205 | 364 |
| Accrued Expenses | 508 | 563 | 1,448 | 1,191 | 1,140 |
| TOTAL | $926 | $793 | $2,070 | $2,396 | $1,504 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $20 | $39 | $N/A |
| Total Liabilities | $926 | $793 | $2,090 | $2,435 | $1,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 133 | 85 | 64 | 42 | 42 |
| Common Shares | 2 | 1 | 12 | 9 | 9 |
| Retained earnings | -144,416 | -138,934 | -131,001 | -112,511 | -96,067 |
| Other shareholders' equity | 0 | 0 | -2 | -19 | 0 |
| TOTAL | $7,610 | $6,032 | $10,275 | $22,194 | $38,070 |
| Total Liabilities And Equity | $8,536 | $6,825 | $12,365 | $24,629 | $39,574 |